![Carole Ho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carole Ho
Director/Board Member at
ROYALTY PHARMA PLC
Net worth: 11 M $ as of 2026-08-30
Profile
Dr. Carole Ho, MD, is an Independent Director at NGM Biopharmaceuticals, Inc., an Independent Director at Beam Therapeutics, Inc. and a Chief Medical Officer & Head-Development at Denali Therapeutics, Inc. She is on the Board of Directors at NGM Biopharmaceuticals, Inc. and Beam Therapeutics, Inc. Dr. Ho was previously employed as a VP-Non Oncology Early Clinical Development by Genentech, Inc. and a Medical Director by Johnson & Johnson. She received her undergraduate degree from Harvard College and a doctorate degree from Weill Cornell Medical College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-08-12 | 424,804 ( 0.27% ) | 10 M $ | 2026-08-30 | |
| 2026-06-04 | 13,103 ( 0% ) | 804 655 $ | 2026-08-30 | |
| 2025-06-03 | 0 ( -.--% ) | - $ | 2026-08-30 |
Carole Ho active positions
| Companies | Position | Start |
|---|---|---|
| ROYALTY PHARMA PLC | Director/Board Member | 2025-07-16 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2025-11-05 |
Former positions of Carole Ho
| Companies | Position | End |
|---|---|---|
| BEAM THERAPEUTICS INC. | Director/Board Member | 2026-02-26 |
| DENALI THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2025-11-05 |
| NGM BIOPHARMACEUTICALS, INC. | Director/Board Member | 2024-04-04 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 2015-05-31 |
| JOHNSON & JOHNSON | Chief Tech/Sci/R&D Officer | 2007-09-30 |
Training of Carole Ho
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
68
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
NGM Biopharmaceuticals, Inc.
 NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Beam Therapeutics, Inc.
 Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Weill Cornell Medicine
 Weill Cornell Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royalty Pharma Plc
 Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties | Health Technology |
- Stock Market
- Insiders
- Carole Ho
